Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud. What Happened: Ginkgo ...

“Our revenue has grown substantially, and we are proud of the progress we've made in establishing strategic partnerships. The robust pipeline of projects we have in place positions us well for ...

We live in the age of the elevator pitch, catchy soundbites, and companies promising to revolutionize every industry under the sun. No other field attracts more visionaries than healthcare. After all, ...

Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API ...

Why a Tech Power Player? For leading one of the region’s most intriguing public companies. Jason Kelly is the cofounder and CEO of Ginkgo Bioworks, a company that aims to program cells like computers.

BOSTON, April 2, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics ...

Ginkgo Bioworks continued its slide from earlier in the week. The company is cutting 25% of its workforce. Two of Cathie Wood's Ark Invest ETFs sold some of their Ginkgo shares. I suspect the Ark ...

Includes $0.3 million and $0.2 million in employer payroll taxes for the three months ended September 30, 2025 and 2024, respectively, and $0.9 million and $2.9 million for the nine months ended ...

Ginkgo is embarking on a cost-cutting plan that could pave the path to profitability and share performance. The main bear case against Ginkgo is there's no compelling reason to buy the stock right now ...